Objective: Deep cervical lymphatic-venous anastomosis (LVA) has shown promise in treating Alzheimer's disease (AD), yet no preoperative tool exists to identify potential responders. We developed and evaluated a novel A {beta} PET based scoring system that quantifies regional amyloid burden according to anatomical proximity to the meningeal lymphatic vessels (MLVs) to predict treatment response. Methods: We retrospectively enrolled 58 AD patients who had undergone upper cervical LVA. Eleven regions of interest (ROIs) adjacent to the superior sagittal and straight sinuses were scored based on anatomical proximity to MLVs (higher = closer) and functional relevance to AD (functional score = 1 for AD-related ROIs), yielding a regional assigned score (RAS). Standardized uptake value ratios (SUVRs) were obtained for each ROI. The total SUVR (Stotal) was calculated as {sum}(SUVR x RAS) over all ROIs, and S4+5 was defined as the same sum restricted to ROIs with RAS 4 or 5. These scores, along with baseline demographic characteristics, were evaluated for their ability to predict treatment response using LASSO-logistic regression and receiver operating characteristic (ROC) curve analysis. Results: Forty-one patients (70.7%) were responders.
Objective: Deep cervical lymphatic-venous anastomosis (LVA) has shown promise in treating Alzheimer's disease (AD), yet no preoperative tool exists to identify potential responders. We developed and evaluated a novel A {beta} PET based scoring system that quantifies regional amyloid burden according to anatomical proximity to the meningeal lymphatic vessels (MLVs) to predict treatment response. Methods: We retrospectively enrolled 58 AD patients who had undergone upper cervical LVA. Eleven regions of interest (ROIs) adjacent to the superior sagittal and straight sinuses were scored based on anatomical proximity to MLVs (higher = closer) and functional relevance to AD (functional score = 1 for AD-related ROIs), yielding a regional assigned score (RAS). Standardized uptake value ratios (SUVRs) were obtained for each ROI. The total SUVR (Stotal) was calculated as {sum}(SUVR x RAS) over all ROIs, and S4+5 was defined as the same sum restricted to ROIs with RAS 4 or 5. These scores, along with baseline demographic characteristics, were evaluated for their ability to predict treatment response using LASSO-logistic regression and receiver operating characteristic (ROC) curve analysis. Results: Forty-one patients (70.7%) were responders. At baseline, responders had significantly higher SUVR of the associative visual cortex (SAVC) (1.68{+/-}0.26 vs. 1.53{+/-}0.12, P=0.0394) and higher S4+5 (32.69{+/-}4.45 vs. 30.14{+/-}3.07, P=0.0358) than non-responders. In univariate analysis, S4+5 was the only significant predictor (OR=1.183, 95% CI: 1.005-1.391, P=0.0433); SAVC was borderline significant (OR=16.654, 95% CI: 0.999-277.63, P=0.0501), while SUVR of the posterior cingulate cortex (SPCC) and Mini-Mental State Examination (MMSE) showed only weak trends (P=0.0714 and P=0.0889, respectively). In the multivariable model, MMSE was independently associated with treatment response (adjusted OR = 1.43, 95% CI: 1.06-1.93, P = 0.022); with SPCC and SUVR of the superior parietal cortex (SsPL) reaching marginal significance (P=0.055 and P=0.051, respectively). The apparent AUC was 0.920, decreasing to a Bootstrap-corrected AUC of 0.780 (95% CI: 0.708-0.884) after optimism correction (optimism = 0.139). The Brier score was 0.097. The covariates-only model yielded a corrected AUC of only 0.574, confirming the incremental value of PET DOI data. Conclusion: This exploratory study introduces a novel A{beta} PET scoring system grounded in MLV anatomy that, combined with baseline MMSE, demonstrates modest predictive potential for LVA response in AD. The findings warrant validation in larger, multicenter cohorts.